Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission

NCT02140255 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

1120

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
DRUG: Nevirapine (NVP)
DRUG: Lopinavir/Ritonavir (LPV/r)
DRUG: Raltegravir (RAL)
DRUG: VRC01
DRUG: Dolutegravir (DTG)
DRUG: VRC07-523LS

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]